Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Small Caps
smallcaps.com.au > article > entropy-neurodynamics-gains-ethics-approval-for-eight-indication-trp-8803-trial

Entropy Neurodynamics Gains Ethics Approval for Eight-Indication TRP-8803 Trial

13+ hour, 2+ min ago   (401+ words) Entropy Neurodynamics gains ethics approval for Phase 1b/2a eight-indication TRP-8803 basket trial; first dosing this quarter. Entropy Neurodynamics (ASX: ENP) has secured Human Research Ethics Committee approval for a Phase 1b/2a basket study of TRP-8803 across eight disorders and signed a Clinical…...

Small Caps
smallcaps.com.au > article > emyria-poised-for-operational-boost-as-tga-broadens-psych-therapy-prescriber-access

Emyria Poised for Operational Boost as TGA Broadens Psych-Therapy Prescriber Access

2+ mon, 1+ week ago   (389+ words) Emyria is set to accelerate recruitment as TGA broadens Authorised Prescriber roles for psychedelic therapy, boosting Empax network expansion into H2 2026. TGA widens Authorised Prescriber pool. H2 2026: more clinics; Empax >100 clinicians. Emyria (ASX: EMD) is set to accelerate its therapist recruitment and…...